The high-af®nity receptor for IgG (FcgRI) is a myeloid cell-speci®c and IFN-g-induced gene, and thereby serves as a paradigm for cytokine-induced cell type-speci®c gene responses. The expression of FcgRI is regulated by PU.1 and Stat1 transcription factors. We established an experimental model to analyze the individual functions of Stat1 and PU.1 in cytokine-induced transcription of the natural FcgRI promoter in U3A cells lacking both factors. PU.1 was required for both the basal activity and for the IFN-g-induced FcgRI promoter activation, while Stat1 alone could not initiate transcription. In contrast, in the context of a heterologous promoter, PU.1 inhibited the Stat1-mediated transcription. Systematic analysis of Stat1 and PU.1 mutants and FcgRI promoter elements revealed that activation of the promoter required the DNA binding, and the transactivation functions of both Stat1 and PU.1. PU.1 and Stat1 bound the promoter elements independently, and no physical interaction between the proteins was observed. The requirement of PU.1 for FcgRI promoter activity was supported by demonstration of in vitro interaction between PU.1 and components of the basal transcription machinery TBP and RNA polymerase II. Deletion of the acidic transactivation domain of PU.1 greatly diminished both the FcgRI promoter activity as well as the interaction with RNA polymerase II. In contrast, Stat1 did not interact with TBP or RNA polymerase II. These results de®ne functional cooperativity between PU.1 and Stat1 in FcgRI promoter activation where PU.1 serves as an ampli®er and bridging factor with the basal transcription machinery.
Introduction
IFN-g plays an important role in the regulation of antiviral and immune responses through binding to the cell-surface IFN-g receptor (IFN-gR) (1) . IFN-g binds as a homodimer to two IFNgR1 chains and two IFN-gR2 subunits are additionally required to assemble an active receptor complex. The IFN-gR1 and IFN-gR2 chains associate with Jak1 and Jak2 tyrosine kinases respectively, and Jaks become activated via receptor oligomerization (2) . Transcriptional responses to IFN-g are largely dependent on Stat1, which is phosphorylated on Tyr701 by the Jak kinases in the receptor complex. The phosphorylated Stat1 forms SH2 domain-mediated homodimers that are translocated to the nucleus where they bind to speci®c regions [termed g-activated sequence (GAS)] on IFN-gresponsive promoters and modulate their transcription (1) .
At the cellular level, IFN-g stimulation results in activation or repression of hundreds of genes (3) . The promoter regions of IFN-g-responsive genes contain response elements for various transcription factors, and the transcriptional responses involve cooperation between different signaling pathways and cell type-and promoter-speci®c factors. Stat1 has been shown to cooperate with Sp1 as well as with AP1 and NF-kB transcription factors (4±6). The mechanisms by which Stats are connected to basal transcriptional machinery and regulate transcription are still largely unknown. However, recent studies have identi®ed some co-activator proteins in Stat signaling. The histone acetyltransferases CREB-binding protein (CBP) and the related protein p300 function as co-activators for numerous transcription factors (7) , and CBP/p300 have also been shown to interact with various Stats (8, 9) . Stat1-mediated transcription has also been shown to involve P/CIP coactivator (10) , and the C-terminal transactivation domain of Stat1 interacts with the DNA replication factor MCM5 and BRCA1 tumor suppressor (11, 12) .
An important question in transcriptional regulation relates to the mechanisms by which relatively limited numbers of transcription factors can provide the speci®city of gene expression. The cell type-speci®c gene expression represents an important model to address these questions. Several transcription factors such as GATA-1, EKLF, GATA-3, Pax5, TCF-1, Ikaros, E2A and PU.1 have been shown to play cell type-speci®c functions for hematopoietic cells of various lineages (13) . Also, some of the IFN-g-induced gene responses show strict cell-type speci®city and one important cell-type-speci®c target for IFN-g is FcgRI (CD64) (14) . FcgRI is the high-af®nity receptor for IgG, which mediates phagocytosis, respiratory burst and antibody-mediated cytotoxic reactions. FcgRI is constitutively expressed on myeloid cells, but the expression of FcgRI is rapidly induced by IFN-g treatment. Characterization of the FcgRI promoter has identi®ed two cis-elements within the 190 nucleotides upstream of the translation initiation site, which confer the IFN-g inducibility and myeloid cell-speci®c expression of the gene. The IFN-g response region (GRR) binds Stat1 and the cell-type-speci®c expression is mediated via a PU.1-binding element (15±17).
PU.1 (Spi-1) is a member of the Ets family of transcription factors which is selectively expressed in myeloid and lymphoid cells. The Ets transcription factors are characterized by a C-terminal winged helix±loop±helix DNA-binding domain (Ets domain). The Ets domain recognizes purine-rich sequences with the core 5¢-GGAA/T-3¢ motif, but some speci®-city for individual Ets proteins is conferred by the¯anking sequences (18) . The N-terminal part of PU.1 contains both acidic and glutamine-rich transactivation domains, and the central part consists of a proline, glutamic acid, serine and threonine-rich region (PEST) domain that mediates protein± protein interactions (19) . PU.1-binding elements are present in several genes that are critical for development and function of myeloid and B cells, such as CSF-1R, CD11b, CD18, GM-CSFR, G-CSFR, IL-7Ra, the macrophage scavenger receptor, PU.1 itself, FcgRI, Ig H and L chain genes, Btk [reviewed in (18, 20) ], and c-rel (21) . The critical role of PU.1 in regulation of these genes largely accounts for the phenotypes of PU.1 ±/± mice that lack B cells, T cells, macrophages and neutrophils due to defects in propagation and differentiation of progenitor cells (22, 23) .
The function of PU.1 in cell differentiation and activation of basal transcription has been extensively studied. Transcription factors such as AML1, C/EBPb, C/EBPd and Myb cooperate with PU.1 in activation of basal transcription, and PU.1 has been shown to associate with C/EBPb, C/EBPd, Rb, TFIID, HMG I/Y and SSRP (24±27). Interestingly, different functional domains of PU.1 are required for regulation of myeloid and B cell differentiation and basal transcription, and also the expression level of PU.1 is a critical determinant in selection between lymphoid and myeloid differentiation (28, 29) . For example, Igk activation is dependent on phosphorylation of Ser148 on PU.1 and interaction with IRF-4, while induction of myeloid differentiation is independent of Ser phosphorylation and the Ets domain, but involves the glutamine-rich transactivation domain of PU.1 (30, 31) . The Ets domain of PU.1 also mediates the interaction with GATA-1, which results in abrogation of PU.1 function and allows erythroid differentiation (32) . The function of PU.1 in cytokine-induced transcriptional activation and its cooperation with Stat factors has been poorly understood.
Methods

Plasmids
The IRF-GAS-luc reporter has been previously characterized (33) . The other reporters were constructed by inserting fragments from FcgRI promoter, made by PCR using human genomic DNA as a template, into NotI±BamHI sites of promoterless pLuc vector (34) . 189/66-DGAS-luc was constructed by mutating CAG (from ±142 to ±140) to ACT to disrupt the Stat1-binding site. TCC sequence from the PU.1-binding site (from ±94 to ±92) was mutated to GAA to give 189/ 66-DPU.1-luc. 189/66-DGASDPU.1-luc harbors both CAG to ACT (from ±142 to ±92) and TCC to GAA (from ±94 to ±92) mutations. The Stat1 expression constructs were made by subcloning the Stat1 cDNAs (kindly provided by Dr J. E. Darnell Jr) (35, 36) into EF-BOS vector (37) containing an HA epitope tag. PU.1 expression plasmids (31) were made by subcloning the PU.1 mutants into pCI-neo vector (Promega, Madison, WI). TBP-glutathione-S-transferase (GST) plasmid was kindly provided by Dr L. Tora.
Cell culture and transfections
Human HeLa cells, monkey COS7 cells and mouse macrophage RAW 264.7 cells were maintained in DMEM, supplemented with 10% FBS. Human monocytic HL-60 cells were grown in RPMI 1640 medium with 10% FBS, and human ®brosarcoma U3A cells, kindly provided by Dr I. Kerr (38) , were cultured in DMEM with 10% Cosmic Calf Serum (Hyclone, Logan, UT).
Transfections of HeLa and U3A cells were performed using the calcium phosphate co-precipitation method. COS7 cells and RAW264.7 cells were transfected by electroporation with a GenePulser (Bio-Rad, Hercules, CA), 260 and 250 V respectively, both 960 mF.
Reporter gene assays RAW 264.7 cells (6 Q 10 6 ) were transfected with 6 mg of luciferase reporter plasmid and 4 mg of pCMV-b-galactosidase plasmid. After electroporation, cells were divided on four 3.5-cm plates per transfection and incubated for 24 h. Cells were starved overnight in DMEM with 1% FBS and treated or left untreated for 6 h with 20 ng/ml murine IFN-g, and lysed in Promega's Reporter Lysis Buffer. Luciferase activity was measured with 1254 Luminova luminometer (ThermoLabsystems, Vantaa, Finland) and normalized against b-galactosidase activity of the lysates.
U3A cells were transfected on six-well plates with 1 mg of reporter plasmid, 500 ng of pCMV-b-galactosidase plasmid and different expression plasmids as indicated in the ®gures. One day after transfection, cells were starved overnight in DMEM with 1% FBS and treated or left untreated for 6 h with 10 ng/ml human IFN-g. Assays were performed as above.
Electrophoretic mobility shift assay (EMSA)
COS7 cells (3 Q 10 6 ) were transfected with 1 mg of Stat1 or with Stat1 and 0.5 mg of PU.1 plasmid, and divided onto two plates. Cells were incubated for 2 days and starved overnight. HL-60 cells, RAW264.7 cells and transfected COS7 cells were treated with 100 ng/ml IFN-g for 15 min or left untreated. Nuclear extracts were prepared as previously described (39) . Binding reactions were performed as described (40) with 6 mg of COS7 nuclear extracts or 10 mg of HL-60 or RAW264.7 extracts and oligonucleotide probe representing FcgRI promoter region from ±189 to +1, prepared by digesting the fragment from FcgRI-luc plasmid.
GST pull-down assay
GST and GST-TBP proteins were produced in BL21 bacteria and puri®ed with glutathione±Sepharose 4B (Amersham Biosciences, Little Chalfont, UK) according to the manufacturer's instructions. COS7 cells (2 Q 10 6 ) were transfected with 2 mg of PU.1 expression vector and after 2 days in culture nuclei were extracted as in the EMSA protocol (39) . Then, 100 mg protein from COS7 extracts or 200 mg protein from HL-60 nuclear extracts in 80 ml of lysis buffer was incubated overnight at 4°C with the GST fusion proteins bound to the glutathione± Sepharose beads in 240 ml of binding buffer (12.5 mM HEPES, pH 7.4, 0.1 mM EDTA, 0.05% Nonidet P-40, 0.5% BSA, 1 mM DTT, 1 mM PMSF and 3 mg/ml aprotinin). The beads were washed 5 times with binding buffer containing 70 mM NaCl. Proteins were boiled in SDS±PAGE sample buffer, separated by 10% SDS±PAGE and analyzed by immunoblot assay with anti-PU.1 or anti-Stat1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA and Transduction Laboratories, Lexington, KY respectively).
In vitro co-immunoprecipitation
COS7 whole-cell extracts were prepared by lysing the cells in a buffer containing 0.5% Nonidet P-40, 50 mM Tris±HCl, pH 8.0, 300 mM NaCl, 1 mM PMSF and 3 mg/ml aprotinin. HeLa nuclear extracts were prepared as in EMSA protocol. COS7 or HeLa extracts were immunoprecipitated with anti-RNA polymerase II antibody (Santa Cruz Biotechnology) in lysis buffer in which NaCl concentration had been adjusted to 100 mM and, after extensive washing, incubated with in vitro translated [ 35 S]methionine-labeled PU.1 wild-type or deletion mutant D33±74 or Stat1. The bound proteins were subjected to SDS± PAGE and visualized by autoradiography.
Results
Stat1 and PU.1 are required to activate IFN-g-induced transcription of FcgRI in a heterologous cell system
To examine the functions of Stat1 and PU.1 in FcgRI promoter activation, the immediate FcgRI promoter (±189 to +1) (17) containing both Stat1 and PU.1 binding elements was cloned into a promoterless luciferase reporter gene vector (FcgRIluc). The basal luciferase reporter gene lacks detectable activity in all of the studied cell lines (RAW264.7, THP-1, HL-60, U3A, HeLa and HepG2). Transfection of FcgRI-luc into murine macrophage RAW264.7 cells resulted in modest basal activation of the reporter gene and IFN-g stimulation resulted in 4-fold induction of transcription (Fig. 1B) . The regulation of the FcgRI-luc is thus reminiscent of the expression pattern of FcgRI on human monocytes (14, 40) . To establish a cellular system that allows investigation of the functional roles of PU.1 and Stat1, regulation of FcgRI-luc was next examined in the U3A ®brosarcoma cell line that lacks both PU.1 and Stat1 proteins (38) . U3A cells were transfected with FcgRI-luc in the presence or absence of Stat1a and PU.1. FcgRI-luc alone did not show either basal or induced activity in U3A cells. Transfection of Stat1a alone did not induce signi®cant reporter activation, but co-transfection of PU.1 and Stat1a resulted in a basal and IFNg-induced FcgRI-luc response that mimics the regulation of reporter gene in myeloid cells. To con®rm the individual roles of Stat1 and PU.1 in the activation of FcgRI, we constructed a promoter construct of FcgRI containing GRR and PU.1 sites (±189 to ±66). U3A cells were transfected with Stat1 and 189/ 66-luc constructs in which the binding site for Stat1 or PU.1, or both sites, had been mutated (189/66-DGAS-luc, 189/66-DPU.1-luc and 189/66-DGASDPU.1-luc respectively). As shown in Fig. 1(C) , 189/66-luc was activated and further induced with IFN-g in the presence of co-transfected PU.1, but mutation of either Stat1 or PU.1 elements abrogated the activity. In RAW264.7 cells, mutation of the Stat1 binding site resulted in the loss of IFN-g inducibility and mutation of the PU.1 element decreased the basal activity of the construct (Fig. 1D) . Thus, the presence of both PU.1 and Stat1 is required for the optimal activation of the FcgRI promoter, con®rming that the model system re¯ects the regulation of the natural FcgRI gene in myeloid cells.
DNA binding and transactivation domains of Stat1 are required for cooperation with PU.1
To determine the structural requirements of Stat1 for transcriptional activation of the FcgRI gene, we compared different Stat1 constructs for their ability to activate transcription of the natural FcgRI promoter and the construct consisting of Stat1 binding site from IRF-1 gene in the context of a heterologous thymidine kinase (TK) promoter (GAS-luc) (33) . Equimolar amounts of Stat1 mutants ( Fig. 2A) , determined by western blotting (data not shown), were expressed in U3A cells together with FcgRI-luc (Fig. 2B) or GAS-luc (Fig. 2C) reporter.
Expression of PU.1 resulted in basal activation of FcgRI-luc, but both PU.1 and wild-type Stat1a were required for IFN-g responsiveness of the reporter gene (Fig. 2B) . The basal activity of FcgRI-luc was not signi®cantly affected by expression or IFN-g-induced activation of Stat1a. However, expression of Stat1a alone was able to mediate a strong IFN-g response in GAS-luc (Fig. 2C) . The naturally occurring splice variant Stat1b that lacks the 38 C-terminal residues of Stat1a constituting the transactivation domain was not able to stimulate either GAS-luc or FcgRI-luc transcription after IFN-g treatment. The DNA binding of Stat1 was required for activation of both promoters, since the DNA-binding-de®cient mutant of Stat1 (Glu428Ala and Glu429Ala) that still undergoes tyrosine phosphorylation and nuclear translocation (41) was unable to activate IFN-g-dependent transcription. Phosphorylation of Stat1 on serine residue 727 has been shown to selectively modulate Stat1-dependent gene responses (42) , and regulate the interaction of Stat1 with MCM5 and BRCA1 proteins (11, 12) . Transfection of U3A cells with Stat1 (Ser727Ala) mutant expression plasmid resulted in diminished IFN-g response of both reporter genes. These results demonstrate that the DNA-binding and the transactivation functions of Stat1 are required for IFN-ginduced activation of both FcgRI-luc and GAS-luc reporter genes. Stat1 binding to the promoter was not suf®cient for transcriptional activation, which requires either the presence of PU.1 or a heterologous promoter. To rule out the possibility that PU.1 could have a general activation effect on transcription, U3A cells were transfected with the GAS-luc construct together with Stat1a and different amounts of PU.1 (Fig. 2D) . Co-transfection of the same amount of PU.1 plasmid (50 ng) that supports FcgRI-luc activation resulted in clear inhibition of the IFN-g-induced transcription of GAS-luc and the inhibition was further substantiated by increasing the amount of transfected PU.1. With FcgRI-luc, increasing the amount of transfected PU.1 slightly enhanced the activation (data not shown). U3A cells were transfected with the FcgRI-luc and Stat1a together with equimolar amounts (determined by western blotting) of different PU.1 constructs (31) (Fig. 3A) . Phosphorylation of PU.1 on Ser148 in response to lipopolysaccharide treatment has been shown to result in enhanced transcriptional activity of PU.1 and to promote interaction with IRF-4 (43). PU.1 expression plasmid in which Ser148 had been mutated into alanine was as ef®cient as wild-type PU.1 in activating both basal and IFN-g-induced transcription of FcgRI promoter (Fig. 3B) . The PEST domain of PU.1 has been shown to be required for protein±protein interactions between PU.1 and IRF-4 in B cells, and also to modulate myeloid differentiation (30) . Deletion of the PEST domain (D118±167) resulted in a slight decrease in the ability of PU.1 to cooperate with Stat1 and to activate basal transcription of FcgRI. The N-terminal half of PU.1 (~100 amino acids) has been shown to harbor multiple transactivation regions (28) . Deletion of the glutamine-rich domain, D75±100, which is required for myeloid differentiation (31), signi®cantly reduced both basal and IFN-ginduced transcription of FcgRI-luc (50% basal and 34% induced activity compared to wild-type PU.1). Deletion of a region rich in acidic amino acids, D33±74, resulted in a protein with less than a third (29%) of the basal activity of wild-type PU.1 and greatly reduced ability (14%) to cooperate with Stat1 in IFN-g-induced transcriptional activation. A mutant containing only the DNA-binding domain of PU.1 (D2±167) failed to support signi®cant basal or IFN-g-induced transcription. Mutant D245±272 that lacks 10 carboxyl amino acids of the DNA-binding domain, and is unable to bind to DNA, was also inactive. These results indicate that the DNA-binding activity of PU.1 is indispensable, but not suf®cient, for FcgRI-luc induction, and both the basal and IFN-g-induced transcription of FcgRI is regulated by glutamine-rich and acidic transactivation regions, and to a lesser extent also by the PEST domain.
Stat1 and PU.1 bind independently to FcgRI promoter
Next, we wanted to gain more insight into the functional cooperation between Stat1 and PU.1 in FcgRI activation. Both Stat1 and PU.1 have been shown to interact with other transcription factors or transcriptional co-regulators (4±6,8,24±27,44), and we analyzed whether their cooperation would involve protein±protein interaction with each other. Coimmunoprecipitation experiments in Stat1-and PU.1-transfected COS7 cells, and with in vitro translated proteins, as well as pull-down experiments with GST-PU.1 failed to demonstrate physical interaction between Stat1 and PU.1 (data not shown). Furthermore, co-expression of PU.1 was not able to To examine whether Stat1 and PU.1 would show cooperative DNA binding, EMSA was performed with the FcgRI probe (nucleotides ±189 to +1). COS7 cells, which lack endogenous PU.1, were transfected with either Stat1 or with Stat1 and PU.1. Nuclear extracts from COS7 cells and from myeloid HL-60 and RAW264.7 cells all showed similar IFN-g-stimulated DNAbinding activity (Fig. 4) 
PU.1, but not Stat1, physically associates with TBP and RNA polymerase II
FcgRI is a TATA-less promoter and next we addressed the question whether Stat1 or PU.1 could function as bridging molecules with general transcription factors (GTF). TBP plays a critical role in the assembly of the pre-initiation complex and previously PU.1 has been shown to interact with TBP in vitro (25) . Also, in our experiments, puri®ed recombinant TBP-GST was found to interact with transfected PU.1 in COS7 cells and with endogenous PU.1 in HL-60 cells (Fig. 5A and B) . The differences in the mobility of PU.1 are likely due to species differences in proteolytic cleavage. In contrast, TBP-GST was not able to interact with Stat1 in IFN-g-treated cells (Fig. 5C) . Also, in unstimulated cells where Stat1 is in a monomeric form, TBP-GST failed to interact with Stat1 (data not shown).
To investigate further the functional roles of Stat1 and PU.1 in transcriptional activation, we examined the possibility that these factors could mediate interaction with RNA polymerase II. To this end, endogenous RNA polymerase II was immunoprecipitated from COS7 cells. The RNA polymerase II immunoprecipitates were washed stringently, and then incubated with in vitro translated Stat1 and PU.1 proteins. After extensive washes the RNA polymerase II-associated proteins were analyzed by autoradiography. PU.1 was found to interact with RNA polymerase II, while no interaction between Stat1 and RNA polymerase II was detected (Fig. 5D) . Deletion of the acidic domain of PU.1 resulted in decreased interaction with RNA polymerase II (Fig. 5E ).
Discussion
We have investigated the mechanisms that underlie cell-typespeci®c gene regulation in IFN-g signaling in the context of the natural FcgRI promoter. We have previously examined the function of co-activator CBP/p300 in FcgRI activation and shown that the function of Stat1 critically requires CBP/p300 (45) . In the present study, we investigated the functional cooperation between Stat1 and PU.1 in more detail, and show that FcgRI promoter activation requires the DNA-binding as well as the transactivation functions of both PU.1 and Stat1. However, the functions of these proteins appear to differ signi®cantly in FcgRI activation. PU.1 mediated the basal activation of the promoter and was found to interact with components of the basal transcription machinery, whereas the function of Stat1 was restricted to IFN-g-stimulated transcription.
FcgRI can be considered as a paradigm for a cell-typespeci®c IFN-g response, where Stat1 and PU.1 cooperatively regulate the promoter activation. The IFN-g-induced optimal FcgRI promoter activation in myeloid and in non-myeloid cells demonstrated an absolute requirement for simultaneous binding of Stat1 and PU.1 to the promoter. PU.1 and Stat1 bound the promoter independently, and no evidence for physical interaction or cooperative DNA binding between PU.1 and Stat1 was detected. These results suggest that the cooperation between Stat1 and PU.1 must rely on modulation of transcriptional activation.
PU.1 is a multifaceted transcription factor that plays a critical role in regulation of numerous genes (18) . The promoter context appears to determine which functional domains of PU.1 are required for transcriptional regulation. We examined the function of PU.1 in cytokine-regulated gene activation, and the results showed that both the DNA-binding Ets domain and the transactivation domains were required for the basal activity of FcgRI promoter as well as for cooperation with Stat1. The DNA-binding domain of PU.1 is a winged helix± turn±helix structure and deletion of the amino acids 245±272 abolishes the DNA interacting wing structure between b sheets 3 and 4 (46) . The requirement for the Ets domain for FcgRI activity was consistent with the EMSA results that showed constitutive DNA binding of PU.1. However, the Ets domain has also been shown to interact with transcriptional regulators such as GATA-1, c-Jun, cytomegalovirus IE2, C/EBPb and C/EBPd, thus the Ets domain deletion could also affect critical interaction with other transcription factors (24, 26, 32, 47, 48) . However, the construct encompassing only the Ets domain of PU.1 did not mediate transcriptional activation, thus the putative interaction with other transcription factors is at least not suf®cient for promoter activation. The cooperation between PU.1 and c-Jun in M-CSF receptor expression also requires the transactivation domains of PU.1, while the cooperation between PU.1 and IE2 on IL-1b gene transcription is independent of the transactivation function of PU.1 (47, 48) . However, in vitro macrophage development requires the glutamine-rich and PEST domains, but not the acidic transactivation domain or the Ets domain of PU.1 (31) . The function of PU.1 on the Igk 3¢ enhancer represents still another variation to the functional requirements of PU.1, as it is dependent only on the DNA-binding activity of PU.1 (49) . Our results indicated that the acidic transactivation domain was absolutely required for FcgRI promoter function and deletion of the glutamine-rich domain also signi®cantly reduced the promoter activity. The differences in requirements for distinct PU.1 functional domains are likely to represent the complexity of gene regulation, and rely on differences in the composition of promoter-bound transcription factors and their interaction with GTF on various PU.1 target genes.
A typical feature for almost all myeloid-speci®c genes including FcgRI is the lack of the TATA element in the promoter region. Instead, these promoters contain an initiator sequence, and PU.1 might function by recruiting TBP and thus allowing assembly of the pre-initiation complex on the promoter. Our results support the role for PU.1 in mediating basal activation through interaction with basal transcription machinery. Consistent with previous results (25) , recombinant TBP-GST interacted with PU.1. However, previously we have shown that a heterologous TATAcontaining promoter could not substitute for the function of PU.1 in FcgRI activation (45) . Alternatively, PU.1 may be mediating other critical functions in FcgRI promoter activation. This hypothesis was supported by the ®ndings that immunoprecipitated RNA polymerase II interacted with in vitro translated PU.1. The acidic transactivation domains have been shown to mediate interaction with transcriptional regulators and with basal transcription factors (50) . In line with these ®ndings, deletion of the acidic transactivation region of PU.1, which was critical for FcgRI promoter activity, compromised the ability of PU.1 to interact with RNA polymerase II. The activation function of PU.1 was promoter dependent since PU.1 inhibited the IFN-g response of the GAS-luc reporter containing a TK promoter. The inhibitory mechanism of PU.1 in the TK promoter is currently unknown, but could involve competition of basal transcription factors on TK promoter, recruitment of histone deacetylases to the promoter or direct repression of CBP acetyltransferase activity by PU.1. PU.1 has been shown to form a complex with histone deacetylase HDAC1 and to repress the activity of c-myc (51). Hong et al., on the other hand, showed that PU.1 inhibits CBP-mediated acetylation of several histone/non-histone proteins and CBP-dependent transcriptional events, and blocks erythroid differentiation by directly binding to CBP (52) . Thus, the role and function of PU.1 in transcriptional regulation is determined by the promoter context.
The molecular mechanisms leading to Stat activation and DNA binding in cytokine signaling are well established. However, most of the studies related to Stat-mediated transcriptional activation have used arti®cial promoters in the context of heterologous promoters thus leaving open the mechanisms by which Stats are connected to basal transcription machinery. Stat1 alone was not able to induce signi®cant promoter activation, which is consistent with the function of PU.1 as a bridging factor for GTF. In accordance with this concept is the lack of any association between Stat1 and either TBP or RNA polymerase II, and the very poor activity of the isolated transactivation domain of Stat1 in a heterologous GAL4 transcription system (data not shown) (53) . However, the transactivation domain of Stat1 was strictly required for FcgRI promoter activation. The transactivation domain of Stat1 has been shown to mediate interaction with CBP (8, 54) . PU.1 has also been shown to interact with CBP, and co-transfection of CBP has been shown to stimulate both PU.1-and Stat1-dependent reporter constructs (8, 44) . By using well-characterized mutants of E1A (55), we previously showed that the function of Stat1 in transcriptional activation was dependent on its ability to recruit CBP/p300 (45) . Recruitment of CBP/ p300 was also involved in, but was not absolutely required for, the function of PU.1. The CBP interaction domain in PU.1 has been mapped to a central region encompassing the glutamine-rich domain and part of the PEST domain (44) . Deletion of these regions reduced, but did not abolish, the transactivation function of PU.1 in the FcgRI promoter, thus also supporting the view that the critical function of PU.1 in the FcgRI promoter is to mediate the interaction with GTF. As previously shown, distinct functional domains of PU.1 are required for activation of different promoters (19) . For Stat1-dependent FcgRI gene activation, the DNA binding and transactivation functions of PU.1 were required since the transactivation domain of Stat1 fails to interact with GTF. However, the transactivation and bridging functions of PU.1 may not be required in promoters where other transcription factors can provide the interaction with GTF, and in these instances the function of PU.1 would be to regulate the holoenzyme assembly.
